Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) Consolidated Diluted EPS At 0.4893

0

For the year ended 2015-12-31 Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) basic consolidated EPS came $0.4896. Furthermore, for the quarter closed 2015-12-31, it was $0.4896.

Consolidated diluted EPS

Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) consolidated diluted EPS was 0.4893 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it stood at $0.4893.

EPS contribution from parent

Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) basic EPS was $0.4896 for the year ended 2015-12-31 from its parent entity. It was $0.4896 for the quarter closed 2015-12-31.

EPS from continuing operations

Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) EPS from continuing activities was $0.4896 for the fiscal ended 2015-12-31. For the quarter ended 2015-12-31, this figure was $0.4896.

Basic net EPS

Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) basic net EPS was $0.49 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it came at $0.49.

Diluted EPS from parent

Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) diluted EPS from parent entity came at $0.4893 for the year ended 2015-12-31. For the quarter ended 2015-12-31 it was $0.4893.

Net diluted EPS

Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) net diluted EPS was $0.49 for the fiscal closed 2015-12-31. For the quarter ended 2015-12-31, net diluted EPS was $0.49.

Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) net basic EPS was $0.49 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it was $0.49.

Basic diluted EPS

Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) basic diluted EPS was $0.0343 for the quarter ended 2015-12-31. For the year ended 2015-12-31, basic diluted EPS was $0.0343.

For the year ended 2015-12-31, basic shares outstanding were 44.197 while for the quarter ended 2015-12-31 is 44.197.

For the fiscal ended 2015-12-31, the diluted outstanding shares were 44.22 and for the quarter ended 2015-12-31 it was 44.22. Earnings per share and diluted EPS are profitability metrics used in fundamental analysis of firms. EPS just takes into account a firm’s common shares, while diluted EPS considers all convertible securities. Per-share earnings measure the quantum of a company’s earnings on a per share basis. Basic EPS does not consider any dilutive impact that convertible securities leave on EPS. On contrary, diluted EPS is a tool used in fundamental study to gauge a firm’s quality of EPS, assuming there is conversion of all convertible securities.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 42 times, 1 visits today)